Sign in

CIK 0000914475 · Large accelerated filer

NEUROCRINE BIOSCIENCES INC

Sign in to watch
Ticker
NBIX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
330525145
Phone
(858) 617-7600
Business address
6027 EDGEWOOD BEND COURT, SAN DIEGO, CA, 92130
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,162,347
in 4 filings, $3.2M under 10b5-1 plans

Net −$3,162,347. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. MORROW GEORGE J −$2.3M Director sold 59% of stake
  2. ABERNETHY MATT −$363K Chief Financial Officer sold 5% of stake
  3. BENEVICH ERIC −$333K Chief Commercial Officer sold 3% of stake
  4. Boyer David W. −$130K Chief Corp. Affairs Officer sold 9% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-09-11 Gano Kyle Chief Executive Officer Shares withheld for taxes −3,386 $156.22 $529K 153,880
2026-09-11 Gano Kyle Chief Executive Officer Grant or award +1,842 155,722
2026-09-11 Gano Kyle Chief Executive Officer Shares withheld for taxes −994 $156.22 $155K 154,728
2026-09-11 Lippoldt Darin Chief Legal Officer Grant or award +4,483 59,212
2026-09-11 Lippoldt Darin Chief Legal Officer Shares withheld for taxes −2,419 $156.22 $378K 56,793
2026-09-11 GORMAN KEVIN CHARLES Director Grant or award +14,343 525,636
2026-09-11 GORMAN KEVIN CHARLES Director Shares withheld for taxes −7,839 $156.22 $1.2M 517,797
2026-09-09 BENEVICH ERIC Chief Commercial Officer Option exercise 10b5-1 +3,194 $43.24 $138K 66,562
2026-09-09 BENEVICH ERIC Chief Commercial Officer Sale 10b5-1 −2,154 $154.61 $333K 64,408
2026-09-09 BENEVICH ERIC Chief Commercial Officer Option exercise · Incentive Stock Option 10b5-1 −3,194 0
2026-09-02 SHERWIN STEPHEN A Director Gift −1,000 14,860
2026-08-04 Onyia Jude Chief Scientific Officer Gift −2,409 20,996
2026-07-29 Norwalk Leslie V Director Option exercise 10b5-1 +842 $139.43 $117K 2,430
2026-07-29 Norwalk Leslie V Director Option exercise · Non-Qualified Stock Option 10b5-1 −842 2,140
2026-07-28 Norwalk Leslie V Director Sale 10b5-1 −1,250 $182.01 $228K 1,588
2026-07-10 Delaet Ingrid Chief Regulatory Officer Option exercise 10b5-1 +4,367 $106.02 $463K 20,592
2026-07-10 Delaet Ingrid Chief Regulatory Officer Sale 10b5-1 −4,367 $181.02 $791K 16,225
2026-07-10 Delaet Ingrid Chief Regulatory Officer Option exercise · Non-Qualified Stock Option 10b5-1 −4,367 0
2026-07-09 Lippoldt Darin Chief Legal Officer Option exercise 10b5-1 +10,000 $81.49 $815K 64,729
2026-07-09 Lippoldt Darin Chief Legal Officer Sale 10b5-1 −10,000 $179.60 $1.8M 54,729

Page 3 of 37 · 740 trades